BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 12912817)

  • 1. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.
    Chen EW; Canto JG; Parsons LS; Peterson ED; Littrell KA; Every NR; Gibson CM; Hochman JS; Ohman EM; Cheeks M; Barron HV;
    Circulation; 2003 Aug; 108(8):951-7. PubMed ID: 12912817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Every NR; Parsons LS; Angeja B; Goldberg RJ; Gore JM; Chou TM;
    Am Heart J; 2001 Jun; 141(6):933-9. PubMed ID: 11376306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; Valk SD; den Uil CA; van der Ent M; Lagrand WK; van de Sande M; van Domburg RT; Simoons ML
    Am J Cardiol; 2009 Aug; 104(3):327-32. PubMed ID: 19616662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients treated with intra-aortic balloon counterpulsation at a tertiary care center in Pakistan - patient characteristics and predictors of in-hospital mortality.
    Jafary FH; Khan SA; Kumar H; Malik NF; Kazmi KA; Dhakam S; Shafquat A; Hameed A; Tai J; Nadeem N
    BMC Cardiovasc Disord; 2004 Dec; 4():22. PubMed ID: 15574201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
    Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.
    Canto JG; Every NR; Magid DJ; Rogers WJ; Malmgren JA; Frederick PD; French WJ; Tiefenbrunn AJ; Misra VK; Kiefe CI; Barron HV
    N Engl J Med; 2000 May; 342(21):1573-80. PubMed ID: 10824077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock.
    Mahmoudi M; Hauville C; Gaglia MA; Sardi G; Torguson R; Xue Z; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2012; 13(6):328-30. PubMed ID: 23062956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications, results of therapy and factors which influence survival in patients treated with intra-aortic balloon counterpulsation.
    Olasińska-Wiśniewska A; Mularek-Kubzdela T; Grajek S; Breborowicz P; Seniuk W; Podzerek T
    Kardiol Pol; 2008 Sep; 66(9):950-5; discussion 956-7. PubMed ID: 18924022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.
    French JK; Feldman HA; Assmann SF; Sanborn T; Palmeri ST; Miller D; Boland J; Buller CE; Steingart R; Sleeper LA; Hochman JS;
    Am Heart J; 2003 Nov; 146(5):804-10. PubMed ID: 14597928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
    Zeymer U; Vogt A; Zahn R; Weber MA; Tebbe U; Gottwik M; Bonzel T; Senges J; Neuhaus KL;
    Eur Heart J; 2004 Feb; 25(4):322-8. PubMed ID: 14984921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cardiogenic shock in myocardial infarction with intraaortic counterpulsation].
    Rumiński W; Markiewicz M; Koziara D; Grzywna R; Lakomski B
    Kardiol Pol; 1993 May; 38(5):323-6. PubMed ID: 8366639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
    Li JL; Xue H; Wang BS; Zhang HY; Yin LH; Shun WD; Wu Y; Wang LX
    Med Sci Monit; 2007 Jun; 13(6):CR270-74. PubMed ID: 17534233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?
    Iakobishvili Z; Behar S; Boyko V; Battler A; Hasdai D
    Am Heart J; 2005 Jan; 149(1):98-103. PubMed ID: 15660040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
    Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
    Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.